Back to search

Article

Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies

2022-02-28

Abstract excerpt

<h4>Introduction</h4> In Alzheimer’s disease clinical research, glial fibrillary acidic protein (GFAP) released into the cerebrospinal fluid and blood is widely measured and perceived as a biomarker of reactive astrogliosis. However, it was demonstrated that GFAP levels differ in individuals presenting with amyloid-β (Aβ) or tau pathology. The molecular underpinnings behind this specificity are unexplored. Here w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6d07a1bd-fb8c-5417-ad03-e9c02be6d9c9
DOI
10.1101/2022.02.25.481812
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologiesDOI 10.1101/2022.02.25.481812
Select a neighboring publication to make it the new centre.